Saturday 17 October 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.
457.58
10.92
−2.33%
Follow HCA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.05 | 16.27 | 16.45 | 16.47 |
+8 more quarters Free account |
P/S ratio |
1.10 | 1.39 | 1.46 | 1.33 | |
P/FCF ratio |
14.34 | 13.35 | 14.35 | 12.26 | |
P/Operating CF |
36.82 | 52.54 | 46.79 | 22.48 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.73 | 2.00 | 2.06 | 1.92 | |
EV/EBITDA |
8.50 | 9.75 | 9.98 | 9.39 | |
EV/Operating CF |
12.11 | 11.76 | 12.33 | 11.12 | |
EV/FCF |
22.46 | 19.29 | 20.26 | 17.63 | |
Quick Ratio |
0.77 | 0.64 | 0.73 | 0.64 | |
Current Ratio |
0.99 | 0.83 | 0.97 | 0.85 | |
Net Debt/EBITDA |
12.06 | 12.35 | 11.02 | 11.22 | |
Debt/Assets |
78.61% | 78.15% | 76.57% | 74.50% | |
Debt/Equity |
(15.49) | (16.13) | (16.78) | (20.62) | |
Asset Turnover |
1.27 | 1.26 | 1.26 | 1.25 | |
Operating CF/Net income |
1.37 | 1.24 | 1.26 | 2.69 | |
Capex/Depreciation |
(1.29) | (1.19) | (1.61) | (1.44) | |
Interest Coverage |
5.15 | 4.92 | 5.60 | 5.31 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
40.98% | 43.35% | 42.84% | 43.65% | |
Intangible Assets out of Total Assets |
0.17 | 0.17 | 0.17 | 0.17 | |
Share Based Compensation of Revenue |
0.42% | 0.45% | 0.51% | 0.54% | |
Graham Net Nets |
(0.57) | (0.46) | (0.43) | (0.47) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
7.66% | 6.14% | 6.08% | 6.07% | |
Free Cash Flow Yield |
6.97% | 7.49% | 6.97% | 8.16% | |
Revenue per Share |
91.73 | 85.47 | 82.54 | 82.27 | |
Operating CF per Share |
10.59 | 9.01 | 9.98 | 18.96 | |
Capex per Share |
(5.58) | (5.00) | (6.30) | (5.53) | |
Free Cash Flow per Share |
5.01 | 4.00 | 3.68 | 13.43 | |
Cash per Share |
4.59 | 4.20 | 4.40 | 4.28 | |
Shareholders Equity per Share |
(14.55) | (13.32) | (11.72) | (9.27) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(14.55) | (13.32) | (11.72) | (9.27) | |
Free Cash Flow |
1,104.00 | 895.00 | 870.00 | 3,128.00 | |
Working Capital |
(122.00) | (3,206.00) | (567.00) | (2,611.00) | |
Capital Expenditures |
(1,231.00) | (1,119.00) | (1,489.00) | (1,288.00) | |
Net Current Asset Value |
(49,269.00) | (48,376.00) | (47,708.00) | (46,621.00) | |
EV/EBIT |
11.10 | 12.70 | 12.94 | 12.21 | |
Capex to Sales |
0.06 | 0.06 | 0.08 | 0.07 | |
Price to Operating Income |
7.08 | 8.79 | 9.16 | 8.49 | |
| Other line items | |||||
Average Receivables |
11,370.00 | 11,206.00 | 10,809.00 | 10,171.50 | |
Average Payables |
4,501.00 | 4,647.00 | 4,467.50 | 4,393.50 | |
Average Inventory |
1,727.00 | 1,737.50 | 1,695.00 | 1,755.00 | |
Average Assets |
61,393.00 | 60,624.00 | 60,116.50 | 59,603.00 | |
Average Common Equity |
(2,223.50) | (1,708.00) | (1,108.00) | (686.50) |
Columns are period end dates